Basic Information
Basic information for NR2F1-AS1-272-22aa-1
Peptide Name NR2F1-AS1-272-22aa-1
Genome Position chr5:93410175-93410240[-]
Species Human
Peptide Sequence MVCLTSQKSEKIEASLFISAAP
Peptide Length 22
Unique No (NR2F1-AS1-201-22aa,NR2F1-AS1-204-22aa-1,NR2F1-AS1-205-22aa,NR2F1-AS1-206-22aa,NR2F1-AS1-207-22aa-1,NR2F1-AS1-208-22aa-1,NR2F1-AS1-210-22aa,NR2F1-AS1-212-22aa,NR2F1-AS1-213-22aa-1,NR2F1-AS1-215-22aa,NR2F1-AS1-216-22aa-1,NR2F1-AS1-217-22aa,NR2F1-AS1-218-22aa,NR2F1-AS1-219-22aa-1,NR2F1-AS1-220-22aa-1,NR2F1-AS1-224-22aa-1,NR2F1-AS1-225-22aa-1,NR2F1-AS1-226-22aa-1,NR2F1-AS1-227-22aa-1,NR2F1-AS1-228-22aa,NR2F1-AS1-230-22aa-1,NR2F1-AS1-231-22aa-1,NR2F1-AS1-232-22aa-1,NR2F1-AS1-233-22aa-1,NR2F1-AS1-234-22aa-1,NR2F1-AS1-235-22aa-1,NR2F1-AS1-236-22aa-1,NR2F1-AS1-238-22aa-1,NR2F1-AS1-239-22aa-1,NR2F1-AS1-240-22aa-1,NR2F1-AS1-241-22aa-1,NR2F1-AS1-243-22aa-2,NR2F1-AS1-245-22aa-1,NR2F1-AS1-247-22aa-1,NR2F1-AS1-248-22aa-1,NR2F1-AS1-249-22aa-1,NR2F1-AS1-251-22aa-1,NR2F1-AS1-252-22aa-1,NR2F1-AS1-254-22aa-1,NR2F1-AS1-255-22aa-1,NR2F1-AS1-256-22aa-1,NR2F1-AS1-257-22aa-1,NR2F1-AS1-258-22aa-1,NR2F1-AS1-259-22aa-1,NR2F1-AS1-260-22aa-1,NR2F1-AS1-261-22aa-1,NR2F1-AS1-262-22aa-1,NR2F1-AS1-264-22aa-1,NR2F1-AS1-266-22aa-1,NR2F1-AS1-267-22aa-1,NR2F1-AS1-268-22aa-1,NR2F1-AS1-273-22aa-1,NR2F1-AS1-274-22aa-1,NR2F1-AS1-275-22aa-1)
Grand Average of Hydropathicity 0.4364
Relative Molecular Mass 2732.1
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000671166;NR2F1-AS1-272
Transcript Length 2576
Coding Ability 0.4453
DNA Sequence Corresponding to Peptide ATGGTGTGCCTCACTAGCCAGAAATCAGAAAAGATCGAAGCTAGCCTTTTCATCTCAGCTGCTCCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :